| Dr. Jorge Santos da Silva | Chief Executive Officer and Interim Chair of the Board | FY2025 | |
| Dr. Kristian Reich | Chief Scientific Officer | FY2025 | |
| Matthias Bodenstedt | Chief Financial Officer | FY2025 |
3 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.